2023
Incarceration and screen-detectable cancer diagnosis among adults in Connecticut
Richman I, Soulos P, Lin H, Aminawung J, Oladeru O, Puglisi L, Wang E, Gross C. Incarceration and screen-detectable cancer diagnosis among adults in Connecticut. Journal Of The National Cancer Institute 2023, 116: 485-489. PMID: 37991935, PMCID: PMC10919339, DOI: 10.1093/jnci/djad242.Peer-Reviewed Original ResearchCancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort study
Aminawung J, Soulos P, Oladeru O, Lin H, Gonsalves L, Puglisi L, Hassan S, Richman I, Wang E, Gross C. Cancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort study. Cancer Medicine 2023, 12: 15447-15454. PMID: 37248772, PMCID: PMC10417084, DOI: 10.1002/cam4.6162.Peer-Reviewed Original ResearchConceptsNon-Hispanic Black individualsScreen-detectable cancersStandardized incidence ratiosNon-Hispanic white individualsCancer incidenceGeneral populationStatewide retrospective cohort studyRetrospective cohort studyWhite individualsState tumor registryLower cancer incidenceBlack individualsHigher cancer incidenceIncarceration exposureCohort studyRetrospective cohortTumor RegistryIncidence ratiosIncarcerated individualsCancer screeningIncidence rateHigh incidenceConnecticut residentsEthnic strataIncidence
2019
Contemporary changes in localized and metastatic prostate cancer incidence by geographic area following decreased PSA screening.
Yang D, Makarov D, Gross C, Yu J. Contemporary changes in localized and metastatic prostate cancer incidence by geographic area following decreased PSA screening. Journal Of Clinical Oncology 2019, 37: 1567-1567. DOI: 10.1200/jco.2019.37.15_suppl.1567.Peer-Reviewed Original ResearchProstate cancer incidenceHealth service areasMetastatic prostate cancerMetastatic prostate cancer incidenceMetastatic diseaseCancer incidenceProstate cancerLocalized diseasePopulation-weighted linear regressionMen 70 yearsEnd Results (SEER) databaseHealth Service regionResults databaseIncidence rateHospital careMetastatic incidenceIncidenceDiseaseCancerLate increasePSALinear regressionMenTemporal relationshipSurveillance
1999
The Relation between Funding by the National Institutes of Health and the Burden of Disease
Gross C, Anderson G, Powe N. The Relation between Funding by the National Institutes of Health and the Burden of Disease. New England Journal Of Medicine 1999, 340: 1881-1887. PMID: 10369852, DOI: 10.1056/nejm199906173402406.Peer-Reviewed Original ResearchMeSH KeywordsBiomedical ResearchCost of IllnessCross-Sectional StudiesDiseaseFederal GovernmentHealth Care RationingHospitalizationHumansMorbidityMortalityNational Institutes of Health (U.S.)Quality-Adjusted Life YearsResearch Support as TopicResource AllocationSickness Impact ProfileSocial ChangeSocial ValuesUnited StatesConceptsBurden of diseaseYears of lifeHospital daysChronic obstructive pulmonary diseaseDisease-specific fundingObstructive pulmonary diseaseCross-sectional studyNational InstituteNIH fundingInstitute of MedicineNumber of deathsDiabetes mellitusPulmonary diseaseImmunodeficiency syndromePeptic ulcerPerinatal conditionsBreast cancerTotal mortalityDiseaseBurdenRegression analysisPrevalenceIncidenceHealthDays